CCCC - C4 Therapeutics Chief People Officer Awarded $267K Worth of Stock Options | Benzinga
Kelly Schick, Chief People Officer at C4 Therapeutics (NASDAQ:CCCC), reported a large acquisition of company stock options on September 19, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Schick, Chief People Officer at C4 Therapeutics, a company in the Health Care sector, was just awarded stock options worth 120,000 shares of CCCC. The options give Schick the right to buy the company's stock at $2.15 per share.
C4 Therapeutics shares are trading up 0.68% at $2.23 at the time of this writing on Wednesday morning. Since the current price is $2.23, this makes Schick's 120,000 ...